DOSE-RESPONSE OF 7 DAY ADMINISTRATION OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) FOR PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH STAGE II-IV BREAST-CANCER
J. Glaspy et al., DOSE-RESPONSE OF 7 DAY ADMINISTRATION OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) FOR PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH STAGE II-IV BREAST-CANCER, Blood, 86(10), 1995, pp. 1837-1837